A131030 Stock Overview
Provides ophthalmic solutions in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
OPTUS Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,430.00 |
| 52 Week High | ₩10,430.00 |
| 52 Week Low | ₩4,970.00 |
| Beta | 0.51 |
| 11 Month Change | -16.59% |
| 3 Month Change | -20.38% |
| 1 Year Change | 4.62% |
| 33 Year Change | -21.08% |
| 5 Year Change | -28.08% |
| Change since IPO | 1.88% |
Recent News & Updates
Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet
Nov 14
Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital
Nov 13Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal
Aug 07Recent updates
Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet
Nov 14Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital
Nov 13Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal
Aug 07There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump
Jun 27There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence
Apr 05DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit
Mar 09DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 10
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 12Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?
Dec 08Shareholder Returns
| A131030 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -0.4% | 8.1% | 2.9% |
| 1Y | 4.6% | 11.5% | -2.8% |
Return vs Industry: A131030 underperformed the KR Medical Equipment industry which returned 11.7% over the past year.
Return vs Market: A131030 exceeded the KR Market which returned -4% over the past year.
Price Volatility
| A131030 volatility | |
|---|---|
| A131030 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A131030 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A131030's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Dong-Hwa Han | www.optuspharm.com |
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name.
OPTUS Pharmaceutical Co., Ltd. Fundamentals Summary
| A131030 fundamental statistics | |
|---|---|
| Market cap | ₩87.71b |
| Earnings (TTM) | ₩10.25b |
| Revenue (TTM) | ₩77.79b |
8.6x
P/E Ratio1.1x
P/S RatioIs A131030 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A131030 income statement (TTM) | |
|---|---|
| Revenue | ₩77.79b |
| Cost of Revenue | ₩34.78b |
| Gross Profit | ₩43.02b |
| Other Expenses | ₩32.77b |
| Earnings | ₩10.25b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 634.40 |
| Gross Margin | 55.30% |
| Net Profit Margin | 13.17% |
| Debt/Equity Ratio | 0% |
How did A131030 perform over the long term?
See historical performance and comparison